Characteristic | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
HR | 95% CI | P-value | HR | 95% CI | P-value | |
Age (year) | ||||||
≤ 70 | Ref | |||||
> 70 | 0.955 | 0.312–2.927 | 0.936 | |||
Sex | ||||||
Male | Ref | |||||
Female | 0.739 | 0.203–2.688 | 0.646 | |||
Tumor length (cm) | ||||||
≤ 3 | Ref | |||||
3–5 | 1.129 | 0.364–3.504 | 0.834 | |||
≥ 5 | 0.396 | 0.048–3.287 | 0.391 | |||
G stage | ||||||
G1 | Ref | |||||
G2 | 1.284 | 0.385–4.289 | 0.684 | |||
G3 | 0.803 | 0.089–7.228 | 0.845 | |||
T stage | ||||||
T1 | Ref | |||||
T2 | 0.145 | 0.013–1.607 | 0.115 | |||
T3 | 0.745 | 0.162–3.421 | 0.705 | |||
N stage | ||||||
N0 | Ref | |||||
N1 | 1.467 | 0.447–4.821 | 0.528 | 1.181 | 0.355–3.930 | 0.768 |
N2–3 | 4.323 | 0.843–22.185 | 0.079* | 7.892 | 1.328–46.911 | 0.023** |
pTNM stage | ||||||
I | Ref | |||||
II | 1.522 | 0.181–13.321 | 0.689 | |||
III–IV | 2.897 | 0.354–23.697 | 0.321 | |||
ERRβsf/ERRβ | ||||||
Low | Ref | Ref | ||||
High | 0.302 | 0.100–0.910 | 0.033** | 0.219 | 0.063–0.767 | 0.018** |